Yesterday
Conference/Events
Show Hide Related Items >> <<
05/31/23 Verastem announces 1-for-12 reverse stock split 05/25/23 Verastem's vutometinib shows 45% response rate in recurrent ovarian cancer 04/26/23 Interim analysis of Verastem's RAMP 201 trial to be presented at ASCO 01/24/23 Verastem reports interim data from Part A of the ongoing RAMP 201 Phase 2 study VIRX Viracta Therapeutics 05/02/23 Viracta Therapeutics CMO Lisa Rojkjaer, M.D to depart 01/19/23 Viracta Therapeutics announces EC orphan drug designation for Nana-val 01/08/23 Viracta announces first clinical response in EBV+ solid tumor setting SWTX SpringsWorks Therapeutics 05/30/23 SpringsWorks Therapeutics says Phase 2 nirogacestat trial fully enrolled 04/17/23 MapKure, SpringWorks, BeiGene present data from Phase 1a/1b study of BGB-3245 02/27/23 SpringsWorks announces FDA acceptance, priority review of nirogacestat NDA 12/27/22 SpringsWorks Therapeutics completes submission of nirogacestat NDA to FDA RVMD Revolution Medicines 12/19/22 Revolution Medicines announces publication on design, synthesis of RMC-5552 12/07/22 Revolution to regain rights to RMC-4630 following Sanofi deal termination 12/07/22 Sanofi terminates SHP2 Inhibitor development pact with Revolution Medicines $740.00 / +8.995 (+1.23%)
05/25/23 Regeneron says updated Linvoseltamab data demonstrates durable responses 05/25/23 Regeneron reports 'positive' data from Fianlimab-Libtayo combo trial 05/21/23 Regeneron, Sanofi present Dupixent late-breaking Phase 3 COPD results 05/18/23 Sanofi 'pleased' with Supreme Court's ruling on Amgen's asserted patent claims ONCT Oncternal Therapeutics 04/03/23 Oncternal Therapeutics falls 41% to 46c per share after drug development halt 04/03/23 Oncternal Therapeutics trading resumes 04/03/23 Oncternal Therapeutics to resume trading at 4:30pm ET 04/03/23 Oncternal Therapeutics halts development of zilovertamab, ibrutinib combination 05/24/23 Mirati Therapeutics falls 10% after SAPPHIRE study did not meet primary endpoint 05/24/23 Mirati Therapeutics trading resumes 05/24/23 Mirati Therapeutics says SAPPHIRE study did not meet primary endpoint 05/24/23 Mirati Therapeutics trading halted, news pending 05/23/23 Moderna, BioNTech other Covid vaccine makers jump amid China Covid scare 05/19/23 Moderna reports interim data from Phase 1/2 trial of mRNA-3927 05/04/23 Moderna up 5% after Q1 results beat estimates 05/04/23 Moderna, Novocol Pharma enter long-term fill-finish agreement 04/17/23 Kinnate Biopharma adds two candidates to pipeline, provides cash runway guidance 04/17/23 Kinnate Biopharma announces 'positive' monotherapy dose escalation data 02/21/23 Kinnate Biopharma acquires ownership stake of Kinnjiu Biopharma for $24M 02/14/23 Kinnate Biopharma granted fast track designation for KIN-3248 from FDA 04/18/23 Immuneering down 5% at $11.53 after pricing $30M stock offering 04/18/23 Immuneering announces initial Phase 1 PK, PD, safety data for IMM-1-104 03/28/23 Immuneering appoints Harold Brakewood as CBO 03/05/23 Immuneering presents preclinical data with lead program IMM-1-104 05/26/23 Gilead announces CHMP reccomendation for the use of Veklury 05/17/23 Gilead to present advances across its oncology pipeline at ASCO Annual Meeting 05/15/23 Arcus Biosciences jumps 2% amid expanded inflammation pact with Gilead 05/15/23 Expanded Gilead- Arcus pact may result in up to $1B in payments to Arcus 05/25/23 Erasca to present HERKULES-3 phase 1b data for ERAS-007 at ASCO 05/16/23 Erasca appoints Davd Chacko as CBO, Nik Chetwyn as COO 05/01/23 Erasca announces U.S. FDA granted FTD to ERAS-801 04/25/23 Erasca announces publication of clinical data on naporafenib DAWN Day One Biopharmaceuticals 01/08/23 Day One announces top line data from pivotal Phase 2 FIREFLY-1 trial 03/06/23 Compugen doses first patient in proof-of-concept study evaluating COM701 02/14/23 Compugen: Rilvegostomig expected to progress into Phase 3 this year 12/06/22 Compugen's COM701 shows durable anti-tumor activity in ovarian cancer 05/01/23 Biomea says FDA clearance of IND application to begin Phase I trial of BMF-500 04/19/23 Biomea Fusion to present late breaking data from Phase II trial, COVALENT-111 03/28/23 Biomea Fusion trading resumes 03/28/23 Biomea Fusion trading halted, volatility trading pause 06/02/23 AstraZeneca's IMFINZI plus chemo improved pathologic response in Phase III trial 06/02/23 AstraZeneca says Imfinzi plus chemotherapy showed clinical benefit in trial 06/01/23 AstraZeneca, Merck announce LYNPARZA + abiraterone approved for BRCAm cancer 06/01/23 Merck and AstraZeneca's Lynparza prostate cancer combination approved by FDA 05/03/23 Agenus up 4% after FDA approves GSK's Arexvy RSV vaccine 04/26/23 Agenus to present Phase 1, Phase 2 trial data at ASCO meeting 04/17/23 Agenus receives Fast Track Designation from FDA for botensilimab, balstilimab 03/27/23 Agenus announces results from cohort in study of botensilimab with balstilimab 05/25/23 EF Hutton Agenus assumed with a Buy at EF Hutton 05/09/23 H.C. Wainwright Agenus's progress continues with data presentations, says H.C. Wainwright 04/20/23 B. Riley B. Riley came away 'encouraged' on Agenus after AACR 02/28/23 H.C. Wainwright Agenus assumed with a Buy at H.C. Wainwright 02/08/23 Jefferies Compugen downgraded to Underperform from Hold at Jefferies 01/04/23 EF Hutton Compugen initiated with a Buy at EF Hutton 11/14/22 Oppenheimer Compugen price target lowered to $8 from $12 at Oppenheimer 08/23/22 Truist Compugen price target lowered to $4 from $14 at Truist DAWN Day One Biopharmaceuticals 05/01/23 Oppenheimer Day One language around NDA submission 'sounded ominous,' says Oppenheimer 05/01/23 H.C. Wainwright Day One pullback brings attractive entry point, says H.C. Wainwright 04/25/23 BofA Day One Biopharmaceuticals double downgraded at BofA on regulatory risks 04/25/23 BofA Day One Biopharmaceuticals downgraded to Underperform from Buy at BofA 03/29/23 Mizuho Erasca initiated with a Buy at Mizuho 02/24/23 Goldman Sachs Erasca initiated with a Buy at Goldman Sachs 02/03/23 Morgan Stanley Erasca upgraded to Overweight from Equal Weight at Morgan Stanley 04/19/23 Mizuho Immuneering upgraded to Buy from Neutral at Mizuho 04/19/23 Morgan Stanley Immuneering upgraded to Equal Weight from Underweight at Morgan Stanley 04/18/23 Chardan Immuneering price target raised to $22 from $18 at Chardan 03/29/23 Mizuho Immuneering initiated with a Neutral at Mizuho 05/18/23 H.C. Wainwright Kinnate Biopharma price target lowered to $24 from $25 at H.C. Wainwright 04/20/23 H.C. Wainwright Kinnate Biopharma price target lowered to $25 from $33 at H.C. Wainwright 04/18/23 Stifel Kinnate Biopharma price target lowered to $5 from $8 at Stifel 04/18/23 Wedbush Kinnate Biopharma price target lowered to $14 from $25 at Wedbush 05/25/23 Oppenheimer Oppenheimer upgrades Mirati to Outperform with Krazati expectations reset 05/25/23 Oppenheimer Mirati Therapeutics upgraded to Outperform from Perform at Oppenheimer 05/25/23 BMO Capital Mirati Therapeutics price target lowered to $40 from $50 at BMO Capital 05/25/23 Barclays Mirati Therapeutics price target lowered to $75 from $90 at Barclays RVMD Revolution Medicines 05/09/23 JPMorgan Revolution Medicines price target lowered to $35 from $38 at JPMorgan 02/28/23 Needham Revolution Medicines price target raised to $38 from $32 at Needham 02/28/23 Oppenheimer Revolution Medicines price target raised to $35 from $30 at Oppenheimer 02/28/23 JPMorgan Revolution Medicines upgraded to Overweight from Neutral at JPMorgan VIRX Viracta Therapeutics 05/10/23 H.C. Wainwright Viracta Therapeutics price target lowered to $33 from $35 at H.C. Wainwright ONCT Oncternal Therapeutics 04/06/23 Cantor Fitzgerald Oncternal downgraded to Neutral from Overweight at Cantor Fitzgerald 04/04/23 Maxim Oncternal Therapeutics downgraded to Hold from Buy at Maxim 04/04/23 Cantor Fitzgerald Oncternal Therapeutics price target lowered to $1.30 from $4.00 at Cantor Fitzgerald 04/04/23 H.C. Wainwright Oncternal Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 05/25/23 EF Hutton Biomea Fusion assumed with a Buy at EF Hutton 05/18/23 Citi Biomea Fusion price target lowered to $53 from $55 at Citi 05/12/23 Barclays Biomea Fusion initiated with an Overweight at Barclays 04/19/23 H.C. Wainwright Biomea Fusion price target lowered to $37 from $44 at H.C. Wainwright 05/31/23 Jefferies Carisma Therapeutics assumed at Buy from Hold at Jefferies 05/05/23 Morgan Stanley Moderna price target lowered to $153 from $185 at Morgan Stanley 04/25/23 Guggenheim Moderna initiated with a Neutral at Guggenheim 04/13/23 Baird Carisma Therapeutics initiated with an Outperform at Baird $740.00 / +8.995 (+1.23%)
05/19/23 Piper Sandler Regeneron Q1 Eylea miss 'not about share, says Piper Sandler 05/08/23 Guggenheim Regeneron price target lowered to $935 from $960 at Guggenheim 05/05/23 Morgan Stanley Regeneron price target raised to $927 from $880 at Morgan Stanley 05/05/23 SVB Securities Regeneron price target lowered to $895 from $976 at SVB Securities 05/26/23 Argus AstraZeneca price target lowered to $80 from $85 at Argus 05/09/23 Berenberg AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg 04/28/23 JPMorgan AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan 04/13/23 Argus AstraZeneca price target raised to $85 from $75 at Argus 06/02/23 Argus Gilead continues to make regulatory progress, says Argus 05/16/23 BMO Capital Gilead upgraded to Outperform from Market Perform at BMO Capital 04/28/23 Piper Sandler Gilead assumed with an Overweight at Piper Sandler 04/12/23 Morgan Stanley Gilead price target raised to $85 from $81 at Morgan Stanley 05/10/23 H.C. Wainwright Verastem price target lowered to $2 from $3 at H.C. Wainwright 03/29/23 Mizuho Verastem initiated with a Neutral at Mizuho 11/07/22 H.C. Wainwright Verastem price target lowered to $3 from $5 at H.C. Wainwright 10/05/22 BTIG Verastem price target lowered to $5 from $8 at BTIG SWTX SpringsWorks Therapeutics 04/28/23 Barclays SpringsWorks Therapeutics price target lowered to $41 from $55 at Barclays 03/07/23 H.C. Wainwright SpringsWorks Therapeutics price target raised to $105 from $99 at H.C. Wainwright 01/02/23 Barclays Barclays views GSK acquisition interest as positive for oncology stocks 12/01/22 BofA SpringsWorks Therapeutics initiated with a Buy, $45 price target at BofA 05/09/23 Verastem reports Q1 EPS (9c), consensus (8c) 03/14/23 Verastem reports Q4 EPS (8c), consensus (10c) VIRX Viracta Therapeutics 05/08/23 Viracta Therapeutics reports Q1 EPS (32c), consensus (31c) 03/13/23 Viracta Therapeutics reports Q4 EPS (27c), consensus (38c) SWTX SpringsWorks Therapeutics 05/03/23 SpringsWorks Therapeutics reports Q1 EPS ($1.18), consensus ($1.25) 02/28/23 SpringsWorks Therapeutics reports Q4 EPS ($1.19), consensus ($1.22) RVMD Revolution Medicines 05/08/23 Revolution Medicines reports Q1 EPS (72c), consensus (81c) 02/27/23 Revolution Medicines sees FY23 net loss $335M-$365M 02/27/23 Revolution Medicines reports Q4 EPS (63c), consensus (82c) $740.00 / +8.995 (+1.23%)
05/04/23 Regeneron reports Q1 adjusted EPS $10.09, consensus $9.56 02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open ONCT Oncternal Therapeutics 05/04/23 Oncternal Therapeutics reports Q1 EPS (20c), consensus (20c) 05/09/23 Mirati Therapeutics reports Q1 EPS ($3.18), consensus ($3.55) 02/28/23 Mirati Therapeutics reports Q4 EPS ($3.51), consensus ($3.55) 05/04/23 Moderna sees Q2 sales $200M-$300M, consensus $982.37M 02/23/23 Moderna reports Q4 EPS $3.61, consensus $4.67 02/22/23 Notable companies reporting before tomorrow's open 05/11/23 Kinnate Biopharma reports Q1 EPS (73c), consensus (73c) 05/15/23 Gilead: Arcus deal may reduce Gilead's FY23 GAAP and non-GAAP EPS by 2c 04/27/23 Gilead backs FY23 adjusted EPS view $6.60-$7.00, consensus $6.84 04/27/23 Gilead reports Q1 Biktarvy sales up 24% y/y 04/27/23 Gilead Sciences reports Q1 adjusted EPS $1.37, consensus $1.54 05/15/23 Erasca reports Q1 EPS (22c), consensus (31c) 03/23/23 Erasca reports Q4 EPS ($1.06) vs. (26c) last year DAWN Day One Biopharmaceuticals 05/01/23 Day One Biopharmaceuticals reports Q1 EPS (59c), consensus (59c) 05/15/23 Compugen reports Q1 EPS (11c), consensus (12c) 03/10/23 Compugen considers exposure to SVB Financial as immaterial 02/27/23 Compugen reports Q4 EPS (4c), consensus (14c) 05/02/23 Biomea Fusion reports Q1 EPS (98c), consensus (81c) 03/28/23 Biomea Fusion reports Q4 EPS (21c), consensus (81c) 04/27/23 AstraZeneca sees FY23 core EPS up high single to low double-digit percentage 04/27/23 AstraZeneca reports Q1 core EPS $1.92, consensus $1.07 02/09/23 AstraZeneca sees FY23 core EPS up high single to low double-digit percentage 02/09/23 AstraZeneca reports Q4 core EPS $1.38, consensus $1.35 05/09/23 Agenus reports Q1 EPS (22c), consensus (21c) 03/14/23 Agenus reports Q4 EPS (24c), consensus (22c)
Hot Stocks
Show Hide Related Items >> <<
06/02/23 Palo Alto Networks to replace Dish in S&P 500 at open on 6/20 05/25/23 Dish jumps 20% after WSJ report on mobile plan talks with Amazon 05/18/23 FCC votes to preserve spectrum between 12.2-12.7 GHz 05/16/23 Dish jumps 6% after director insider transactions 05/12/23 Cutera comments on termination of poxy solicitation by Voce Capital 05/11/23 Cutera shareholder Voce Capital terminates proxy solicitation 05/09/23 Cutera announces agreements with Pura Vida, RTW 04/18/23 Plants, Mowry say Cutera special committee made 'misleading' statements 06/02/23 JPMorgan JPMorgan 'most comfortable defending' T-Mobile after Amazon wireless headlines 05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 05/25/23 Citi Citi downgrades Dish to Neutral on 'substantial capital needs' 05/24/23 Citi Dish downgraded to Neutral from Buy at Citi 05/11/23 William Blair Cutera downgraded to Market Perform from Outperform at William Blair 05/10/23 Cantor Fitzgerald Cutera price target lowered to $21 from $33 at Cantor Fitzgerald 05/10/23 Piper Sandler Cutera reinstated with an Underweight at Piper Sandler 03/30/23 Maxim Cutera downgraded to Hold from Buy at Maxim 05/08/23 Dish reports Q1 EPS 35c, consensus 36c 02/23/23 Dish reports Q4 EPS $1.47, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open 05/09/23 Cutera reports Q1 EPS ($1.26), consensus (39c) 04/12/23 Cutera withdraws FY23 outlook 02/28/23 Cutera sees FY23 revenue $277M-$292M, consensus $300.7M 02/28/23 Cutera reports Q4 EPS (40c), consensus (24c) 06/02/23 Amazon tells Reuters 'don't have plans to add wireless at this time' 06/02/23 Amazon in talks to offer low-cost or free Prime phone service, Bloomberg says 05/25/23 Dish in discussions to sell wireless plans via Amazon, WSJ reports 05/18/23 Ergen flew to Dubai to seek cash for struggling Dish, NY Post says 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/08/23 What You Missed On Wall Street On Monday 05/09/23 Fly Intel: After-Hours Movers 04/30/23 Short Report: Bears boost Vivid Seats position to record high as stock bottoms 04/12/23 What You Missed On Wall Street On Wednesday 04/12/23 What You Missed On Wall Street This Morning 06/02/23 Dish Network call volume above normal and directionally bullish 06/02/23 Early notable gainers among liquid option names on June 2nd 05/16/23 Early notable gainers among liquid option names on May 16th 03/09/23 Early notable gainers among liquid option names on March 9th
Hot Stocks
Show Hide Related Items >> <<
$217.23 / +0.475 (+0.22%)
05/23/23 Palo Alto Networks expects supply chains to normalize exiting FY23 05/23/23 Palo Alto Networks says deal scrutiny has increased 05/23/23 Palo Alto Networks sees FY23 adjusted free cash flow margin 37.5%-38.5% 04/25/23 Accenture, Palo Alto Networks collaborate to deliver SASE solutions 05/25/23 Dish jumps 20% after WSJ report on mobile plan talks with Amazon 05/18/23 FCC votes to preserve spectrum between 12.2-12.7 GHz 05/16/23 Dish jumps 6% after director insider transactions 05/08/23 Dish says it has 'narrow window of opportunity' to address capital structure $217.23 / +0.475 (+0.22%)
06/02/23 Stephens SentinelOne downgraded to Equal Weight from Overweight at Stephens 05/30/23 RBC Capital Crowdstrike price target raised to $180 from $170 at RBC Capital 05/24/23 Deutsche Bank Palo Alto Networks price target raised to $225 from $210 at Deutsche Bank 05/24/23 Loop Capital Palo Alto Networks price target raised to $240 from $225 at Loop Capital 06/02/23 JPMorgan JPMorgan 'most comfortable defending' T-Mobile after Amazon wireless headlines 05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 05/25/23 Citi Citi downgrades Dish to Neutral on 'substantial capital needs' 05/24/23 Citi Dish downgraded to Neutral from Buy at Citi $217.23 / +0.475 (+0.22%)
05/23/23 Palo Alto Networks raises FY23 adjusted EPS view to $4.25-$4.29 from $3.97-$4.03 05/23/23 Palo Alto Networks sees Q4 adjusted EPS $1.26-$1.30, consensus $1.20 05/23/23 Palo Alto Networks reports Q3 adjusted EPS $1.10, consensus 93c 05/23/23 Notable companies reporting after market close 05/08/23 Dish reports Q1 EPS 35c, consensus 36c 02/23/23 Dish reports Q4 EPS $1.47, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open $217.23 / +0.475 (+0.22%)
03/15/23 Microsoft says Russia's spring offensive may include new cyberattacks, NYT says 01/06/23 White House to unveil cybersecurity strategy, Washington Post reports 06/02/23 Amazon tells Reuters 'don't have plans to add wireless at this time' 06/02/23 Amazon in talks to offer low-cost or free Prime phone service, Bloomberg says 05/25/23 Dish in discussions to sell wireless plans via Amazon, WSJ reports 05/18/23 Ergen flew to Dubai to seek cash for struggling Dish, NY Post says $217.23 / +0.475 (+0.22%)
05/24/23 What You Missed On Wall Street On Wednesday 05/24/23 What You Missed On Wall Street This Morning 05/24/23 Fly Intel: Pre-market Movers 05/23/23 Fly Intel: After-Hours Movers 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/08/23 What You Missed On Wall Street On Monday $217.23 / +0.475 (+0.22%)
06/01/23 Unusually active option classes on open June 1st 05/23/23 Palo Alto Networks options imply 6.8% move in share price post-earnings 02/21/23 Palo Alto Networks options imply 6.7% move in share price post-earnings 06/02/23 Dish Network call volume above normal and directionally bullish 06/02/23 Early notable gainers among liquid option names on June 2nd 05/16/23 Early notable gainers among liquid option names on May 16th 03/09/23 Early notable gainers among liquid option names on March 9th
Conference/Events
Show Hide Related Items >> <<
$740.00 / +8.995 (+1.23%)
05/25/23 Regeneron says updated Linvoseltamab data demonstrates durable responses 05/25/23 Regeneron reports 'positive' data from Fianlimab-Libtayo combo trial 05/21/23 Regeneron, Sanofi present Dupixent late-breaking Phase 3 COPD results 05/18/23 Sanofi 'pleased' with Supreme Court's ruling on Amgen's asserted patent claims 05/25/23 PDS Biotechnology announces 'promising' interim data from VERSATILE-002 trial 05/18/23 PDS Biotechnology completes enrollment in VERSATILE-002 Phase 2 trial 05/15/23 PDS Biotechnology expects cash to fund programs into 3Q24 04/27/23 PDS Biotechnology to present updated data from VERSATILE-002 study 05/25/23 Oncolytics reports positive response data in Phase 2 breast cancer trial 12/08/22 Oncolytics' Chinese partner presents interim data on breast cancer candidate 06/02/23 Novartis says Kisqali reduced risk of breast cancer recurrence by 25% in study 06/01/23 Pharming to sell PRV to Novartis for $21.1M 05/25/23 EMA accepts Sandoz marketing authorization applications for biosimilar denosumab 05/22/23 Avrobio to sell HSC gene therapy program to Novartis for $87.5M in cash 05/18/23 Mustang Bio announces strategic manufacturing partnership, portfolio updates 04/03/23 Mustang Bio announces 15-for-1 reverse stock split 12/19/22 Mustang Bio provides CAR T cell therapy portfolio updates 05/31/23 Janssen says Tremfya showed 'sustainable improvements' in psoriatic arthritis 05/25/23 Legend: Type II variation application submitted to EMA for CARVYKTI 05/25/23 Bristol-Myers granted FDA Fast Track Designation for 3 milvexian indications 05/12/23 Protagonist and Janssen report data from preclinical studies of JNJ-2113 05/25/23 I-Mab announces results from CD73 antibody combination study 04/25/23 Tracon announces $23M arbitration award in dispute with I-Mab 04/25/23 I-Mab receives arbitration award relating to Tracon CD73 antibody pact 04/24/23 I-Mab doses first patient in Phase 3 study of lemzoparlimab in MDS in China 05/25/23 Takeda, Hutchmed say Fruquintinib NDA granted priority review by FDA 04/17/23 Hutchmed announces NDA acceptance for Fruquintinib in China 04/04/23 Hutchmed initiates registration phase of HMPL-453 trial 03/14/23 Hutchmed announces closing of fruquintinib license to Takeda 05/26/23 Gilead announces CHMP reccomendation for the use of Veklury 05/17/23 Gilead to present advances across its oncology pipeline at ASCO Annual Meeting 05/15/23 Arcus Biosciences jumps 2% amid expanded inflammation pact with Gilead 05/15/23 Expanded Gilead- Arcus pact may result in up to $1B in payments to Arcus EFTR eFfector Therapeutics 05/25/23 eFfector Therapeutics' zotatifin shows positive Phase 2 breast cancer results 04/11/23 eFfector Therapeutics to collaborate with Standford Medicine 02/21/23 eFfector announces top-line results from Phase 1b trial of zotatifin 01/05/23 eFfector Therapeutics provides clinical data update for Zotatifin 05/30/23 Bristol-Myers' repotrectinib application in lung cancer accepted by FDA 05/26/23 Bristol-Myers reports CHMP opinion recommending approval for Opdivo combination 05/25/23 Bristol-Myers to present first results from Phase 3 COMMANDS study of Reblozyl 05/25/23 Bristol-Myers says Breyanzi first and only CAR-T to deliver efficacy in CLL/SLL 05/25/23 Aravive to present 'promising' update from phase 2 trial of Batiraxcept at ASCO 05/16/23 Aravive announces Phase 3 trial design for batiraxcept 05/08/23 Aravive to host virtual KOL event on batiraxcept 04/26/23 Aravive announces poster presentation at ASCO 05/23/23 JonesResearch Oncolytics initiated with a Buy at JonesResearch 03/06/23 Canaccord Oncolytics price target lowered to $5.00 from $6.00 at Canaccord 03/06/23 Cantor Fitzgerald Oncolytics initiated with an Overweight at Cantor Fitzgerald 04/03/23 Piper Sandler I-Mab price target lowered to $25 from $30 at Piper Sandler 04/03/23 H.C. Wainwright I-Mab price target lowered to $25 from $45 at H.C. Wainwright 08/31/22 H.C. Wainwright I-Mab price target lowered to $45 from $70 at H.C. Wainwright 08/30/22 Piper Sandler I-Mab price target lowered to $30 from $35 at Piper Sandler 02/27/23 H.C. Wainwright H.C. Wainwright reiterates Buy on PDS following positive FDA meeting 01/03/23 H.C. Wainwright PDS Biotechnology price target raised to $21 from $15 at H.C. Wainwright 12/28/22 B. Riley PDS Biotechnology price target raised to $12 from $10 at B. Riley 11/14/22 Chardan PDS Biotechnology price target raised to $16 from $15 at Chardan EFTR eFfector Therapeutics 05/26/23 Mizuho eFfector Therapeutics posted positive breast cancer data, says Mizuho 05/26/23 Stifel eFfector Therapeutics upgraded to Buy from Hold at Stifel 03/15/23 H.C. Wainwright Aravive price target raised to $12 from $7 at H.C. Wainwright 01/04/23 EF Hutton Aravive initiated with a Buy at EF Hutton 11/13/22 Piper Sandler Aravive price target lowered to $2 from $6 at Piper Sandler 10/27/22 Roth MKM Aravive price target lowered to $10 from $15 at Roth Capital 05/30/23 RBC Capital Kenvue initiated with an Outperform at RBC Capital 05/30/23 Citi Johnson & Johnson resumed with a Buy at Citi 05/30/23 JPMorgan JPMorgan starts Kenvue with Overweight on 'resilient growth' 05/30/23 Goldman Sachs Kenvue initiated with a Neutral at Goldman Sachs 05/01/23 Barclays Bristol-Myers price target lowered to $65 from $66 at Barclays 04/28/23 Credit Suisse Bristol-Myers price target lowered to $72 from $78 at Credit Suisse 04/21/23 BofA Bristol-Myers price target raised to $85 from $82 at BofA 04/20/23 H.C. Wainwright Legend Biotech price target raised to $77 from $66 at H.C. Wainwright $740.00 / +8.995 (+1.23%)
05/19/23 Piper Sandler Regeneron Q1 Eylea miss 'not about share, says Piper Sandler 05/08/23 Guggenheim Regeneron price target lowered to $935 from $960 at Guggenheim 05/05/23 Morgan Stanley Regeneron price target raised to $927 from $880 at Morgan Stanley 05/05/23 SVB Securities Regeneron price target lowered to $895 from $976 at SVB Securities 06/02/23 Argus Gilead continues to make regulatory progress, says Argus 05/16/23 BMO Capital Gilead upgraded to Outperform from Market Perform at BMO Capital 04/28/23 Piper Sandler Gilead assumed with an Overweight at Piper Sandler 04/12/23 Morgan Stanley Gilead price target raised to $85 from $81 at Morgan Stanley 05/19/23 JPMorgan JPMorgan places 'Negative Catalyst Watch' on Novartis into data 04/26/23 Barclays Novartis price target raised to CHF 90 from CHF 85 at Barclays 04/26/23 Credit Suisse Novartis price target raised to CHF 90 from CHF 80 at Credit Suisse 04/26/23 JPMorgan Novartis price target raised to CHF 92 from CHF 85 at JPMorgan 05/26/23 B. Riley Mustang Bio price target raised to $10 from $4 at B. Riley 11/16/22 BTIG Mustang Bio price target lowered to $4 from $8 at BTIG 08/17/22 BTIG Bluebird's approval has positive read for Mustang Bio, says BTIG 07/14/22 B. Riley Mustang Bio price target lowered to $4 from $5 at B. Riley $740.00 / +8.995 (+1.23%)
05/04/23 Regeneron reports Q1 adjusted EPS $10.09, consensus $9.56 02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 05/15/23 PDS Biotechnology reports Q1 EPS (32c), consensus (31c) 03/28/23 PDS Biotechnology reports 2022 EPS ($1.43), consensus ($1.08) 03/03/23 Oncolytics reports Q4 EPS (C$0.14) vs. (C$0.14) last year 04/25/23 Novartis reports Q1 EPS $1.71, consensus $1.55 02/01/23 Novartis sees core operating income to grow mid single digit percentage in 2023 02/01/23 Novartis reports Q4 core EPS $1.52, consensus $1.44 05/12/23 Mustang Bio reports Q1 EPS ($2.06) vs. ($2.71) last year 04/18/23 Johnson & Johnson raises FY23 adjusted EPS to $10.60-$10.70 from $10.45-$10.65 04/18/23 Johnson & Johnson reports Q1 adjusted EPS $2.68, consensus $2.51 04/17/23 Notable companies reporting before tomorrow's open 02/28/23 Fate Therapeutics reports Q4 EPS (58c), consensus (86c) 05/15/23 Gilead: Arcus deal may reduce Gilead's FY23 GAAP and non-GAAP EPS by 2c 04/27/23 Gilead backs FY23 adjusted EPS view $6.60-$7.00, consensus $6.84 04/27/23 Gilead reports Q1 Biktarvy sales up 24% y/y 04/27/23 Gilead Sciences reports Q1 adjusted EPS $1.37, consensus $1.54 EFTR eFfector Therapeutics 05/09/23 eFfector Therapeutics reports Q1 EPS (24c), consensus (14c) 03/08/23 eFfector Therapeutics reports Q4 EPS (22c), consensus (24c) 04/27/23 Bristol-Myers backs FY23 adjusted EPS view $7.95-$8.25, consensus $8.06 04/27/23 Bristol-Myers reports Q1 adjusted EPS $2.05, consensus $1.97 04/26/23 Notable companies reporting before tomorrow's open 05/10/23 Aravive reports Q1 EPS (66c), consensus (32c) 03/15/23 Aravive reports Q4 EPS (46c), consensus (30c) $740.00 / +8.995 (+1.23%)
05/17/23 Regeneron CEO backs regulators attempt to block Amgen deal, FT reports 04/14/23 FDA resuming China lab inspections could benefit Amicus, BeiGene, Barron's says 03/22/23 Novartis halts Leqvio heart attack prevention trial, Reuters reports 02/08/23 Avrobio exploring potential sale after approach, Street Insider says 12/29/22 Novartis to pay $245M to settle lawsuit on Exforge medicine, Bloomberg reports 05/26/23 Health authorities to target next COVID shot to new strain, WSJ says 05/23/23 Amgen, J&J settle patent lawsuit over Stelara biosimilar, Reuters reports 05/10/23 New suitors showing interest in ShockWave Medical, Street Insider says 05/03/23 Johnson & Johnson's Kenvue to price at $22 per share, Bloomberg says 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says $740.00 / +8.995 (+1.23%)
03/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/24/23 What You Missed On Wall Street On Friday 03/24/23 What You Missed On Wall Street This Morning 01/03/23 What You Missed On Wall Street On Tuesday 01/03/23 What You Missed On Wall Street This Morning 05/24/23 Biotech Alert: Searches spiking for these stocks today 05/22/23 Fly Intel: Pre-market Movers 03/22/23 What You Missed On Wall Street On Wednesday 03/22/23 What You Missed On Wall Street This Morning 06/02/23 Buy/Sell: Wall Street's top 10 stock calls this week 05/30/23 What You Missed On Wall Street On Tuesday 05/30/23 What You Missed On Wall Street This Morning 05/30/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/25/23 Fly Intel: After-Hours Movers 05/16/23 What You Missed On Wall Street On Tuesday 05/16/23 What You Missed On Wall Street This Morning 05/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations EFTR eFfector Therapeutics 05/26/23 What You Missed On Wall Street On Friday 05/26/23 What You Missed On Wall Street This Morning 03/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/02/23 Fly Intel: Pre-market Movers 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations $740.00 / +8.995 (+1.23%)
03/23/23 Early notable gainers among liquid option names on March 23rd 12/13/22 Largest borrow rate increases among liquid names 01/09/23 Novartis call volume above normal and directionally bullish 12/16/22 Novartis call volume above normal and directionally bullish 04/18/23 Unusually active option classes on open April 18th 04/06/23 Unusually active option classes on open April 6th 04/05/23 Early notable gainers among liquid option names on April 5th 04/05/23 Unusually active option classes on open April 5th 05/25/23 Gilead call volume above normal and directionally bullish 05/03/23 Gilead call volume above normal and directionally bullish 04/27/23 Gilead options imply 3.8% move in share price post-earnings 02/03/23 Early notable gainers among liquid option names on February 3rd 03/10/23 Bristol Myers Squibb put volume heavy and directionally bearish 02/24/23 Bristol Myers Squibb put volume heavy and directionally bearish
Recommendations
Show Hide Related Items >> <<
05/31/23 Verizon lands $145.7M digital modernization contract with USPS 05/19/23 Verizon upgrades network at Indianapolis Motor Speedway 05/16/23 Verizon to allow customers to customize plan in U.S. 05/04/23 Verizon lands $448.3M Veterans Affairs contract $127.16 / -11.735 (-8.45%)
05/22/23 T-Mobile CEO sees Q2 postpaid phone nets 'at or above last year's' level 04/24/23 T-Mobile extends collaboration with VA, will be primary wireless provider 04/18/23 Clevon chooses T-Mobile as preferred connectivity provider for robot fleet 04/06/23 T-Mobile expands deal with MLB, MiLB, Little League Baseball and Softball 05/11/23 AT&T, BlackRock launch Gigapower joint venture 04/20/23 AT&T says Q1 free cash flow 'within our expectations' 04/20/23 AT&T says 'particularly proud' of quality of subscriber additions 04/20/23 AT&T targets net debt-to-adjusted EBITDA ratio of 2.5x range by early 2025 05/25/23 Dish jumps 20% after WSJ report on mobile plan talks with Amazon 05/18/23 FCC votes to preserve spectrum between 12.2-12.7 GHz 05/16/23 Dish jumps 6% after director insider transactions 05/08/23 Dish says it has 'narrow window of opportunity' to address capital structure 06/01/23 Congressman Comer probes Federal Trade Commission Chair Khan's 'abuses of power' 06/01/23 EU sets July 6 provisional deadline for review of iRobot, Amazon deal 05/31/23 FTC, DOJ fine Amazon $25M for children's privacy law violations 05/30/23 Amazon Web Services announces general availability of Amazon Security Lake $127.16 / -11.735 (-8.45%)
05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 05/19/23 Tigress Financial T-Mobile selloff 'major buying opportunity,' says Tigress Financial 05/08/23 RBC Capital SBA Communications price target lowered to $290 from $320 at RBC Capital 05/04/23 Loop Capital Altice USA price target lowered to $3 from $12 at Loop Capital 06/02/23 Piper Sandler Pinterest, Amazon partnership should be 'win-win,' says Piper Sandler 06/01/23 Stifel Veritone price target lowered to $4 from $5 at Stifel 06/01/23 Roth MKM Veritone downgraded to Neutral from Buy at Roth MKM 05/31/23 Bernstein Amazon.com price target raised to $140 from $125 at Bernstein 05/25/23 Citi Citi downgrades Dish to Neutral on 'substantial capital needs' 05/24/23 Citi Dish downgraded to Neutral from Buy at Citi 05/09/23 JPMorgan Dish price target lowered to $16 from $18 at JPMorgan 05/15/23 BofA AT&T management has 'high conviction' in free cash flow guidance, says BofA 05/03/23 Citi Citi places 'Positive Catalyst Watch' on AT&T ahead of disclosures 04/28/23 Barclays AT&T price target lowered to $18 from $19 at Barclays 04/26/23 TD Cowen Verizon price target lowered to $45 from $49 at TD Cowen 04/21/23 Rosenblatt Calix price target lowered to $70 from $75 at Rosenblatt 04/20/23 KeyBanc T-Mobile new Uncarrier plan could be a negative for AT&T, Verizon, says KeyBanc 04/25/23 Verizon sees Fy23 adjusted EPS $4.55-$4.85, consensus $4.70 04/25/23 Verizon reports Q1 adjusted EPS $1.20, consensus $1.20 04/24/23 Notable companies reporting before tomorrow's open $127.16 / -11.735 (-8.45%)
04/27/23 T-Mobile raises FY23 core adjusted EBITDA view $28.8B-$29.3B from $28.7B-$29.2B 04/27/23 T-Mobile reports Q1 EPS $1.58, consensus $1.48 04/27/23 Notable companies reporting after market close 02/01/23 T-Mobile reports Q4 EPS $1.18, consensus $1.10 04/20/23 AT&T reports Q1 adjusted EPS 60c, consensus 58c 04/19/23 Notable companies reporting before tomorrow's open 01/25/23 AT&T sees FY23 adjusted EPS $2.35-$2.45, consensus $2.56 05/08/23 Dish reports Q1 EPS 35c, consensus 36c 02/23/23 Dish reports Q4 EPS $1.47, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open 04/27/23 Amazon sees Q2 revenue $127B-$133B, consensus $129.83B 04/27/23 Amazon reports Q1 EPS 31c with Rivian loss, consensus 21c 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B 05/15/23 Verizon Chief Marketing Officer stepping down, WSJ reports 01/10/23 Best Buy-owned Lively faces complaints after 3G shutdown, WSJ reports $127.16 / -11.735 (-8.45%)
06/02/23 Amazon tells Reuters 'don't have plans to add wireless at this time' 06/02/23 Amazon in talks to offer low-cost or free Prime phone service, Bloomberg says 04/20/23 T-Mobile proposed takeover of Mint faces DOJ scrutiny, NY Post says 03/13/23 SpaceX to test Starlink's satellite-to-cell service with T-Mobile, CNBC reports 02/26/23 Microsoft unveils suit of cloud tools for telecom companies, Reuters says 02/21/23 AT&T seeking to shed cybersecurity division, Reuters reports 05/25/23 Dish in discussions to sell wireless plans via Amazon, WSJ reports 05/18/23 Ergen flew to Dubai to seek cash for struggling Dish, NY Post says 06/01/23 North America fulfillment head to depart Amazon, CNBC reports 06/01/23 Amazon uses A.I. to screen items for damage, WSJ reports 05/31/23 What You Missed On Wall Street This Morning 05/15/23 What You Missed On Wall Street This Morning $127.16 / -11.735 (-8.45%)
06/02/23 Fly Intel: Pre-market Movers 04/27/23 Fly Intel: After-Hours Movers 04/21/23 What You Missed On Wall Street On Friday 04/21/23 What You Missed On Wall Street This Morning 04/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/08/23 What You Missed On Wall Street On Monday 06/01/23 What You Missed On Wall Street On Thursday 06/01/23 What You Missed On Wall Street This Morning 05/31/23 What You Missed On Wall Street On Wednesday 03/15/23 Verizon call volume above normal and directionally bullish 12/15/22 Verizon call volume above normal and directionally bullish $127.16 / -11.735 (-8.45%)
06/02/23 Unusually active option classes on open June 2nd 05/31/23 Early notable gainers among liquid option names on May 31st 05/02/23 T Mobile put volume heavy and directionally bearish 04/27/23 T Mobile options imply 3.3% move in share price post-earnings 05/25/23 AT&T call volume above normal and directionally bullish 04/21/23 Notable open interest changes for April 21st 04/20/23 Unusually active option classes on open April 20th 06/02/23 Dish Network call volume above normal and directionally bullish 06/02/23 Early notable gainers among liquid option names on June 2nd 05/16/23 Early notable gainers among liquid option names on May 16th 03/09/23 Early notable gainers among liquid option names on March 9th 05/30/23 Notable open interest changes for May 30th 05/25/23 Amazon call buyer realizes 3% same-day gains 05/23/23 Notable open interest changes for May 23rd 05/17/23 Notable open interest changes for May 17th
Options
Show Hide Related Items >> <<
05/25/23 Dish jumps 20% after WSJ report on mobile plan talks with Amazon 05/18/23 FCC votes to preserve spectrum between 12.2-12.7 GHz 05/16/23 Dish jumps 6% after director insider transactions 05/08/23 Dish says it has 'narrow window of opportunity' to address capital structure 05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 05/25/23 Citi Citi downgrades Dish to Neutral on 'substantial capital needs' 05/24/23 Citi Dish downgraded to Neutral from Buy at Citi 05/09/23 JPMorgan Dish price target lowered to $16 from $18 at JPMorgan 05/08/23 Dish reports Q1 EPS 35c, consensus 36c 02/23/23 Dish reports Q4 EPS $1.47, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open 06/02/23 Amazon tells Reuters 'don't have plans to add wireless at this time' 06/02/23 Amazon in talks to offer low-cost or free Prime phone service, Bloomberg says 05/25/23 Dish in discussions to sell wireless plans via Amazon, WSJ reports 05/18/23 Ergen flew to Dubai to seek cash for struggling Dish, NY Post says 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/08/23 What You Missed On Wall Street On Monday 06/02/23 Early notable gainers among liquid option names on June 2nd 05/16/23 Early notable gainers among liquid option names on May 16th 03/09/23 Early notable gainers among liquid option names on March 9th 03/07/23 Early notable gainers among liquid option names on March 7th
Options
Show Hide Related Items >> <<
05/12/23 Treasury ties domestically produced steel to IRA tax credit 04/19/23 Steel Dynamics sees 'solid' domestic steel consumption 02/27/23 Steel Dynamics increases quarterly dividend 25% to 42.5c per share 02/09/23 Steel Dynamics names Barry Schneider COO 04/25/23 Otis Worldwide raises quarterly dividend 17.2% to 34c per share 02/27/23 Otis Worldwide appoints Sally Loh as President, Otis China 12/21/22 Otis Worldwide achieves Gold-level TRUE certification for zero waste efforts 05/16/23 Newell Brands cuts quarterly dividend to 7c per share from 23c 05/15/23 Icahn bought Illumina in Q1, sold shares of Herc and Newell 05/05/23 Newell Brands CFO purchases nearly $1M of shares 03/20/23 Newell Brands credit rating cut to junk by S&P Global 05/25/23 Dish jumps 20% after WSJ report on mobile plan talks with Amazon 05/18/23 FCC votes to preserve spectrum between 12.2-12.7 GHz 05/16/23 Dish jumps 6% after director insider transactions 05/08/23 Dish says it has 'narrow window of opportunity' to address capital structure 06/02/23 Chemours, DuPont, Corteva reach PFAS settlement with U.S. water systems 05/15/23 Third Point buys Alibaba, cuts AIG in Q1 05/02/23 DuPont to acquire Spectrum Plastics Group from AEA Investors for $1.75B 02/14/23 Third Point buys AIG, exits T-Mobile in Q4 05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 05/25/23 Citi Citi downgrades Dish to Neutral on 'substantial capital needs' 05/24/23 Citi Dish downgraded to Neutral from Buy at Citi 05/09/23 JPMorgan Dish price target lowered to $16 from $18 at JPMorgan 05/15/23 Deutsche Bank DuPont upgraded to Buy from Hold at Deutsche Bank 05/04/23 RBC Capital DuPont price target lowered to $81 from $92 at RBC Capital 05/03/23 Deutsche Bank DuPont price target lowered to $70 from $82 at Deutsche Bank 05/03/23 BMO Capital DuPont price target lowered to $84 from $103 at BMO Capital 05/16/23 Deutsche Bank Newell dividend cut confirmation of constraints, says Deutsche Bank 05/01/23 Deutsche Bank Newell Brands price target lowered to $13 from $14 at Deutsche Bank 03/20/23 Deutsche Bank Newell Brands price target lowered to $14 from $16 at Deutsche Bank 02/16/23 Citi Citi launches beverage, personal space with six buys, two sells 05/23/23 JPMorgan Steel Dynamics initiated with an Underweight at JPMorgan 05/05/23 UBS Steel Dynamics price target lowered to $100 from $110 at UBS 04/21/23 Credit Suisse Steel Dynamics price target raised to $115 from $106 at Credit Suisse 04/05/23 BofA Steel Dynamics downgraded to Neutral from Buy at BofA 05/01/23 Wells Fargo Wells Fargo upgrades Otis Worldwide to Equal Weight, raises price target to $88 05/01/23 Wells Fargo Otis Worldwide upgraded to Equal Weight from Underweight at Wells Fargo 04/19/23 HSBC Otis Worldwide price target raised to $81 from $72 at HSBC 04/06/23 Barclays Otis Worldwide price target lowered to $79 from $81 at Barclays 04/19/23 Steel Dynamics reports Q1 adjusted EPS $4.01, consensus $3.52 03/15/23 Steel Dynamics sees Q1 adjusted EPS $3.78-$3.82, consensus $3.11 01/25/23 Steel Dynamics reports Q4 adjusted EPS $4.37, consensus $3.79 12/15/22 Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84 04/26/23 Otis Worldwide raises FY23 adjusted EPS view to $3.40-$3.50 from $3.35-$3.50 04/26/23 Otis Worldwide reports Q1 EPS 80c, consensus 73c 02/01/23 Otis Worldwide sees FY23 adjusted EPS $3.35-$3.50, consensus $3.44 02/01/23 Otis Worldwide reports Q4 adjusted EPS 75c, consensus 74c 04/28/23 Newell Brands backs FY23 normalized EPS view 95c-$1.08, consensus $1.03 04/28/23 Newell Brands sees Q2 normalized EPS 10c-18c, consensus 38c 04/28/23 Newell Brands reports Q1 normalized EPS (6c), consensus (3c) 04/27/23 Notable companies reporting before tomorrow's open 05/08/23 Dish reports Q1 EPS 35c, consensus 36c 02/23/23 Dish reports Q4 EPS $1.47, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open 05/02/23 DuPont narrows FY23 adjusted EPS view to $3.55-$3.70 from $3.50-$4.00 05/02/23 DuPont sees Q2 EPS 84c, consensus $1.10 05/02/23 DuPont reports Q1 adjusted EPS 84c, consensus $1.13 02/07/23 DuPont sees FY23 adjusted EPS $3.50-$4.00, consensus $3.84 12/05/22 U.S, EU weigh tariffs on Chinese steel, aluminum, Bloomberg says 06/02/23 Amazon tells Reuters 'don't have plans to add wireless at this time' 06/02/23 Amazon in talks to offer low-cost or free Prime phone service, Bloomberg says 05/25/23 Dish in discussions to sell wireless plans via Amazon, WSJ reports 05/18/23 Ergen flew to Dubai to seek cash for struggling Dish, NY Post says 06/01/23 Trian co-founder Ed Garden steps down, amid reshuffling at firm, WSJ says 06/01/23 PFAS makers settle Roma, Georgia suit for over $100M, Bloomberg says 05/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/15/23 Fly Intel: Pre-market Movers 12/16/22 What You Missed On Wall Street On Friday 04/28/23 Fly Intel: Pre-market Movers 02/10/23 What You Missed On Wall Street On Friday 02/10/23 What You Missed On Wall Street This Morning 02/10/23 Fly Intel: Pre-market Movers 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/08/23 What You Missed On Wall Street On Monday 06/02/23 Fly Intel: Pre-market Movers 06/01/23 What You Missed On Wall Street On Thursday 05/15/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/07/23 What You Missed On Wall Street On Tuesday 04/19/23 Steel Dynamics options imply 3.6% move in share price post-earnings 01/25/23 Steel Dynamics options imply 3.0% move in share price post-earnings 02/23/23 Early notable gainers among liquid option names on February 23rd 02/22/23 Newell Brands call volume above normal and directionally bullish 02/10/23 Unusually active option classes on open February 10th 05/16/23 Early notable gainers among liquid option names on May 16th 03/09/23 Early notable gainers among liquid option names on March 9th 03/07/23 Early notable gainers among liquid option names on March 7th 03/03/23 Early notable gainers among liquid option names on March 3rd 02/07/23 Early notable gainers among liquid option names on February 7th 01/19/23 DuPont de Nemours put volume heavy and directionally bearish
Periodicals
Show Hide Related Items >> <<
05/31/23 Verizon lands $145.7M digital modernization contract with USPS 05/19/23 Verizon upgrades network at Indianapolis Motor Speedway 05/16/23 Verizon to allow customers to customize plan in U.S. 05/04/23 Verizon lands $448.3M Veterans Affairs contract $138.89 / -0.005 (-0.00%)
05/22/23 T-Mobile CEO sees Q2 postpaid phone nets 'at or above last year's' level 04/24/23 T-Mobile extends collaboration with VA, will be primary wireless provider 04/18/23 Clevon chooses T-Mobile as preferred connectivity provider for robot fleet 04/06/23 T-Mobile expands deal with MLB, MiLB, Little League Baseball and Softball 05/11/23 AT&T, BlackRock launch Gigapower joint venture 04/20/23 AT&T says Q1 free cash flow 'within our expectations' 04/20/23 AT&T says 'particularly proud' of quality of subscriber additions 04/20/23 AT&T targets net debt-to-adjusted EBITDA ratio of 2.5x range by early 2025 05/25/23 Dish jumps 20% after WSJ report on mobile plan talks with Amazon 05/18/23 FCC votes to preserve spectrum between 12.2-12.7 GHz 05/16/23 Dish jumps 6% after director insider transactions 05/08/23 Dish says it has 'narrow window of opportunity' to address capital structure 06/01/23 Congressman Comer probes Federal Trade Commission Chair Khan's 'abuses of power' 06/01/23 EU sets July 6 provisional deadline for review of iRobot, Amazon deal 05/31/23 FTC, DOJ fine Amazon $25M for children's privacy law violations 05/30/23 Amazon Web Services announces general availability of Amazon Security Lake 06/02/23 Piper Sandler Pinterest, Amazon partnership should be 'win-win,' says Piper Sandler 06/01/23 Stifel Veritone price target lowered to $4 from $5 at Stifel 06/01/23 Roth MKM Veritone downgraded to Neutral from Buy at Roth MKM 05/31/23 Bernstein Amazon.com price target raised to $140 from $125 at Bernstein 05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 04/26/23 TD Cowen Verizon price target lowered to $45 from $49 at TD Cowen 04/21/23 Rosenblatt Calix price target lowered to $70 from $75 at Rosenblatt 04/20/23 KeyBanc T-Mobile new Uncarrier plan could be a negative for AT&T, Verizon, says KeyBanc 05/15/23 BofA AT&T management has 'high conviction' in free cash flow guidance, says BofA 05/03/23 Citi Citi places 'Positive Catalyst Watch' on AT&T ahead of disclosures 04/28/23 Barclays AT&T price target lowered to $18 from $19 at Barclays $138.89 / -0.005 (-0.00%)
05/19/23 Tigress Financial T-Mobile selloff 'major buying opportunity,' says Tigress Financial 05/08/23 RBC Capital SBA Communications price target lowered to $290 from $320 at RBC Capital 05/04/23 Loop Capital Altice USA price target lowered to $3 from $12 at Loop Capital 05/25/23 Citi Citi downgrades Dish to Neutral on 'substantial capital needs' 05/24/23 Citi Dish downgraded to Neutral from Buy at Citi 05/09/23 JPMorgan Dish price target lowered to $16 from $18 at JPMorgan 04/25/23 Verizon sees Fy23 adjusted EPS $4.55-$4.85, consensus $4.70 04/25/23 Verizon reports Q1 adjusted EPS $1.20, consensus $1.20 04/24/23 Notable companies reporting before tomorrow's open $138.89 / -0.005 (-0.00%)
04/27/23 T-Mobile raises FY23 core adjusted EBITDA view $28.8B-$29.3B from $28.7B-$29.2B 04/27/23 T-Mobile reports Q1 EPS $1.58, consensus $1.48 02/01/23 T-Mobile reports Q4 EPS $1.18, consensus $1.10 04/20/23 AT&T reports Q1 adjusted EPS 60c, consensus 58c 04/19/23 Notable companies reporting before tomorrow's open 01/25/23 AT&T sees FY23 adjusted EPS $2.35-$2.45, consensus $2.56 05/08/23 Dish reports Q1 EPS 35c, consensus 36c 02/23/23 Dish reports Q4 EPS $1.47, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open 04/27/23 Amazon sees Q2 revenue $127B-$133B, consensus $129.83B 04/27/23 Amazon reports Q1 EPS 31c with Rivian loss, consensus 21c 04/27/23 Notable companies reporting after market close 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B 05/15/23 Verizon Chief Marketing Officer stepping down, WSJ reports 01/10/23 Best Buy-owned Lively faces complaints after 3G shutdown, WSJ reports 12/20/22 FCC partisan deadlock shields wireless companies from $200M fine, WSJ reports $138.89 / -0.005 (-0.00%)
04/20/23 T-Mobile proposed takeover of Mint faces DOJ scrutiny, NY Post says 03/13/23 SpaceX to test Starlink's satellite-to-cell service with T-Mobile, CNBC reports 02/17/23 Goldman pulls out of talks to launch co-branded card for T-Mobile US, WSJ says 02/26/23 Microsoft unveils suit of cloud tools for telecom companies, Reuters says 02/21/23 AT&T seeking to shed cybersecurity division, Reuters reports 01/12/23 DirecTV lays off hundreds of employees, Deadline reports 05/25/23 Dish in discussions to sell wireless plans via Amazon, WSJ reports 05/18/23 Ergen flew to Dubai to seek cash for struggling Dish, NY Post says 03/10/23 Peloton hit with U.S. import ban over streaming technology, Reuters reports 06/02/23 Amazon in talks to offer low-cost or free Prime phone service, Bloomberg says 06/01/23 North America fulfillment head to depart Amazon, CNBC reports 06/01/23 Amazon uses A.I. to screen items for damage, WSJ reports 05/31/23 FTC settles privacy lawsuit with Amazon's Ring, Reuters reports 05/31/23 What You Missed On Wall Street This Morning 05/15/23 What You Missed On Wall Street This Morning $138.89 / -0.005 (-0.00%)
04/27/23 Fly Intel: After-Hours Movers 04/21/23 What You Missed On Wall Street On Friday 04/21/23 What You Missed On Wall Street This Morning 04/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/08/23 What You Missed On Wall Street On Monday 06/02/23 Fly Intel: Pre-market Movers 06/01/23 What You Missed On Wall Street On Thursday 06/01/23 What You Missed On Wall Street This Morning 05/31/23 What You Missed On Wall Street On Wednesday 06/02/23 Unusually active option classes on open June 2nd 04/20/23 Unusually active option classes on open April 20th 03/15/23 Verizon call volume above normal and directionally bullish 12/15/22 Verizon call volume above normal and directionally bullish $138.89 / -0.005 (-0.00%)
05/31/23 Early notable gainers among liquid option names on May 31st 05/02/23 T Mobile put volume heavy and directionally bearish 04/27/23 T Mobile options imply 3.3% move in share price post-earnings 05/25/23 AT&T call volume above normal and directionally bullish 04/21/23 Notable open interest changes for April 21st 05/16/23 Early notable gainers among liquid option names on May 16th 03/09/23 Early notable gainers among liquid option names on March 9th 03/07/23 Early notable gainers among liquid option names on March 7th 03/03/23 Early notable gainers among liquid option names on March 3rd 05/30/23 Notable open interest changes for May 30th 05/25/23 Amazon call buyer realizes 3% same-day gains 05/23/23 Notable open interest changes for May 23rd 05/17/23 Notable open interest changes for May 17th
Recommendations
Show Hide Related Items >> <<
05/30/23 Pinterest names Julia Brau Donnelly as new CFO 05/15/23 Elliott bought Reservoir Media in Q1, sold Aerojet and News Corp. 05/15/23 Tiger Management adds Nvidia in Q1, sells out of Toast and Chevron 04/27/23 Pinterest teams with Amazon to bring third-party ad demand to platform 06/01/23 Congressman Comer probes Federal Trade Commission Chair Khan's 'abuses of power' 06/01/23 EU sets July 6 provisional deadline for review of iRobot, Amazon deal 05/31/23 FTC, DOJ fine Amazon $25M for children's privacy law violations 05/30/23 Amazon Web Services announces general availability of Amazon Security Lake 05/02/23 Loop Capital Pinterest price target lowered to $28 from $32 at Loop Capital 04/28/23 Rosenblatt Pinterest price target raised to $27 from $26 at Rosenblatt 04/28/23 BofA Pinterest price target lowered to $29 from $30 at BofA 06/01/23 Stifel Veritone price target lowered to $4 from $5 at Stifel 06/01/23 Roth MKM Veritone downgraded to Neutral from Buy at Roth MKM 05/31/23 Bernstein Amazon.com price target raised to $140 from $125 at Bernstein 05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 04/27/23 Pinterest reports Q1 EPS 8c, consensus 1c 04/27/23 Notable companies reporting after market close 02/06/23 Pinterest reports Q4 EPS 29c, consensus 27c 02/06/23 Notable companies reporting after market close 04/27/23 Amazon sees Q2 revenue $127B-$133B, consensus $129.83B 04/27/23 Amazon reports Q1 EPS 31c with Rivian loss, consensus 21c 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B 05/03/23 TikTok launching ad product for publishers, giving a 50% cut, WSJ says 04/09/23 Pinterest staging turnaround, stock looking like a buy, Barron's says 03/26/23 House speaker says lawmakers to move forward with TikTok bill, Reuters says 03/26/23 Banning TikTok in U.S. easier said than done, WSJ says 06/02/23 Amazon in talks to offer low-cost or free Prime phone service, Bloomberg says 06/01/23 North America fulfillment head to depart Amazon, CNBC reports 06/01/23 Amazon uses A.I. to screen items for damage, WSJ reports 05/31/23 FTC settles privacy lawsuit with Amazon's Ring, Reuters reports 05/31/23 #SocialStocks: Meta seeks federal court intervention in FTC sanctions 05/17/23 #SocialStocks: Tech companies seek employees abroad after hiring freeze 05/03/23 #SocialStocks: TikTok and Pinterest announce new ad offerings 04/28/23 What You Missed On Wall Street On Friday 06/01/23 What You Missed On Wall Street On Thursday 06/01/23 What You Missed On Wall Street This Morning 05/31/23 What You Missed On Wall Street On Wednesday 05/30/23 What You Missed On Wall Street This Morning 04/27/23 Pinterest options imply 7.6% move in share price post-earnings 03/14/23 Unusually active option classes on open March 14th 03/10/23 Pinterest put volume heavy and directionally bearish 02/06/23 Pinterest options imply 12.0% move in share price post-earnings 05/30/23 Notable open interest changes for May 30th 05/25/23 Amazon call buyer realizes 3% same-day gains 05/23/23 Notable open interest changes for May 23rd 05/17/23 Notable open interest changes for May 17th
Periodicals
Show Hide Related Items >> <<
05/31/23 Verizon lands $145.7M digital modernization contract with USPS 05/19/23 Verizon upgrades network at Indianapolis Motor Speedway 05/16/23 Verizon to allow customers to customize plan in U.S. 05/04/23 Verizon lands $448.3M Veterans Affairs contract 05/22/23 T-Mobile CEO sees Q2 postpaid phone nets 'at or above last year's' level 04/24/23 T-Mobile extends collaboration with VA, will be primary wireless provider 04/18/23 Clevon chooses T-Mobile as preferred connectivity provider for robot fleet 04/06/23 T-Mobile expands deal with MLB, MiLB, Little League Baseball and Softball 05/11/23 AT&T, BlackRock launch Gigapower joint venture 04/20/23 AT&T says Q1 free cash flow 'within our expectations' 04/20/23 AT&T says 'particularly proud' of quality of subscriber additions 04/20/23 AT&T targets net debt-to-adjusted EBITDA ratio of 2.5x range by early 2025 05/25/23 Dish jumps 20% after WSJ report on mobile plan talks with Amazon 05/18/23 FCC votes to preserve spectrum between 12.2-12.7 GHz 05/16/23 Dish jumps 6% after director insider transactions 05/08/23 Dish says it has 'narrow window of opportunity' to address capital structure 06/01/23 Congressman Comer probes Federal Trade Commission Chair Khan's 'abuses of power' 06/01/23 EU sets July 6 provisional deadline for review of iRobot, Amazon deal 05/31/23 FTC, DOJ fine Amazon $25M for children's privacy law violations 05/30/23 Amazon Web Services announces general availability of Amazon Security Lake 06/01/23 Stifel Veritone price target lowered to $4 from $5 at Stifel 06/01/23 Roth MKM Veritone downgraded to Neutral from Buy at Roth MKM 05/31/23 Bernstein Amazon.com price target raised to $140 from $125 at Bernstein 05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 04/26/23 TD Cowen Verizon price target lowered to $45 from $49 at TD Cowen 04/21/23 Rosenblatt Calix price target lowered to $70 from $75 at Rosenblatt 04/20/23 KeyBanc T-Mobile new Uncarrier plan could be a negative for AT&T, Verizon, says KeyBanc 05/15/23 BofA AT&T management has 'high conviction' in free cash flow guidance, says BofA 05/03/23 Citi Citi places 'Positive Catalyst Watch' on AT&T ahead of disclosures 04/28/23 Barclays AT&T price target lowered to $18 from $19 at Barclays 05/19/23 Tigress Financial T-Mobile selloff 'major buying opportunity,' says Tigress Financial 05/08/23 RBC Capital SBA Communications price target lowered to $290 from $320 at RBC Capital 05/04/23 Loop Capital Altice USA price target lowered to $3 from $12 at Loop Capital 05/25/23 Citi Citi downgrades Dish to Neutral on 'substantial capital needs' 05/24/23 Citi Dish downgraded to Neutral from Buy at Citi 05/09/23 JPMorgan Dish price target lowered to $16 from $18 at JPMorgan 04/25/23 Verizon sees Fy23 adjusted EPS $4.55-$4.85, consensus $4.70 04/25/23 Verizon reports Q1 adjusted EPS $1.20, consensus $1.20 04/24/23 Notable companies reporting before tomorrow's open 04/27/23 T-Mobile raises FY23 core adjusted EBITDA view $28.8B-$29.3B from $28.7B-$29.2B 04/27/23 T-Mobile reports Q1 EPS $1.58, consensus $1.48 02/01/23 T-Mobile reports Q4 EPS $1.18, consensus $1.10 04/20/23 AT&T reports Q1 adjusted EPS 60c, consensus 58c 04/19/23 Notable companies reporting before tomorrow's open 01/25/23 AT&T sees FY23 adjusted EPS $2.35-$2.45, consensus $2.56 05/08/23 Dish reports Q1 EPS 35c, consensus 36c 02/23/23 Dish reports Q4 EPS $1.47, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open 04/27/23 Amazon sees Q2 revenue $127B-$133B, consensus $129.83B 04/27/23 Amazon reports Q1 EPS 31c with Rivian loss, consensus 21c 04/27/23 Notable companies reporting after market close 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B 05/15/23 Verizon Chief Marketing Officer stepping down, WSJ reports 01/10/23 Best Buy-owned Lively faces complaints after 3G shutdown, WSJ reports 12/20/22 FCC partisan deadlock shields wireless companies from $200M fine, WSJ reports 04/20/23 T-Mobile proposed takeover of Mint faces DOJ scrutiny, NY Post says 03/13/23 SpaceX to test Starlink's satellite-to-cell service with T-Mobile, CNBC reports 02/17/23 Goldman pulls out of talks to launch co-branded card for T-Mobile US, WSJ says 01/11/23 T-Mobile considers acquisition of Ryan Reynolds' Mint Mobile, Bloomberg says 02/26/23 Microsoft unveils suit of cloud tools for telecom companies, Reuters says 02/21/23 AT&T seeking to shed cybersecurity division, Reuters reports 01/12/23 DirecTV lays off hundreds of employees, Deadline reports 12/26/22 AT&T to build broadband services outside its current markets, WSJ reports 05/25/23 Dish in discussions to sell wireless plans via Amazon, WSJ reports 05/18/23 Ergen flew to Dubai to seek cash for struggling Dish, NY Post says 03/10/23 Peloton hit with U.S. import ban over streaming technology, Reuters reports 06/01/23 North America fulfillment head to depart Amazon, CNBC reports 06/01/23 Amazon uses A.I. to screen items for damage, WSJ reports 05/31/23 FTC settles privacy lawsuit with Amazon's Ring, Reuters reports 05/31/23 FTC files suit against Amazon's Ring unit, Reuters reports 05/31/23 What You Missed On Wall Street This Morning 05/15/23 What You Missed On Wall Street This Morning 04/25/23 What You Missed On Wall Street On Tuesday 04/27/23 Fly Intel: After-Hours Movers 03/15/23 What You Missed On Wall Street On Wednesday 04/21/23 What You Missed On Wall Street On Friday 04/21/23 What You Missed On Wall Street This Morning 04/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/20/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/08/23 What You Missed On Wall Street On Monday 06/01/23 What You Missed On Wall Street On Thursday 06/01/23 What You Missed On Wall Street This Morning 05/31/23 What You Missed On Wall Street On Wednesday 05/30/23 What You Missed On Wall Street This Morning 04/20/23 Unusually active option classes on open April 20th 03/15/23 Verizon call volume above normal and directionally bullish 12/15/22 Verizon call volume above normal and directionally bullish 12/15/22 Early notable gainers among liquid option names on December 15th 05/31/23 Early notable gainers among liquid option names on May 31st 05/02/23 T Mobile put volume heavy and directionally bearish 04/27/23 T Mobile options imply 3.3% move in share price post-earnings 04/04/23 T Mobile put volume heavy and directionally bearish 05/25/23 AT&T call volume above normal and directionally bullish 04/21/23 Notable open interest changes for April 21st 04/04/23 Unusually active option classes on open April 4th 05/16/23 Early notable gainers among liquid option names on May 16th 03/09/23 Early notable gainers among liquid option names on March 9th 03/07/23 Early notable gainers among liquid option names on March 7th 03/03/23 Early notable gainers among liquid option names on March 3rd 05/30/23 Notable open interest changes for May 30th 05/25/23 Amazon call buyer realizes 3% same-day gains 05/23/23 Notable open interest changes for May 23rd 05/17/23 Notable open interest changes for May 17th
